BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7937716)

  • 1. An immunohistochemical study of thyroid Hurthle cells and their neoplasms: the roles of S-100 and HMB-45 proteins.
    Abu-Alfa AK; Straus FH; Montag AG
    Mod Pathol; 1994 Jun; 7(5):529-32. PubMed ID: 7937716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.
    Erickson LA; Jin L; Goellner JR; Lohse C; Pankratz VS; Zukerberg LR; Thompson GB; van Heerden JA; Grant CS; Lloyd RV
    Mod Pathol; 2000 Feb; 13(2):186-92. PubMed ID: 10697277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
    Elliott DD; Pitman MB; Bloom L; Faquin WC
    Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Hashimoto's thyroiditis from thyroid neoplasms in fine needle aspirates.
    Ravinsky E; Safneck JR
    Acta Cytol; 1988; 32(6):854-61. PubMed ID: 3201876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential diagnosis of oxyphilic (Hürthle cell) adenomas and carcinomas of the thyroid].
    Tret'iakova MS; Bussolati J
    Arkh Patol; 2000; 62(6):14-8. PubMed ID: 11198115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
    Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
    BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of immunoreactive corticotropin releasing hormone in thyroid lesions.
    Scopa CD; Mastorakos G; Friedman TC; Melachrinou M; Merino MJ; Chrousos GP
    Am J Pathol; 1994 Nov; 145(5):1159-67. PubMed ID: 7977646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMB-45 detection in adenocarcinomas.
    Hancock C; Allen BC; Herrera GA
    Arch Pathol Lab Med; 1991 Sep; 115(9):886-90. PubMed ID: 1718237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of S-100 protein in renal cell neoplasms.
    Lin F; Yang W; Betten M; Teh BT; Yang XJ;
    Hum Pathol; 2006 Apr; 37(4):462-70. PubMed ID: 16564922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases.
    Cochand-Priollet B; Molinié V; Bougaran J; Bouvier R; Dauge-Geffroy MC; Deslignières S; Fournet JC; Gros P; Lesourd A; Saint-André JP; Toublanc M; Vieillefond A; Wassef M; Fontaine A; Groleau L
    Arch Pathol Lab Med; 1997 Oct; 121(10):1081-6. PubMed ID: 9341588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
    Gleason BC; Nascimento AF
    Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncocytic variant of papillary thyroid carcinoma associated with Hashimoto's thyroiditis: a case report and review of the literature.
    Lee J; Hasteh F
    Diagn Cytopathol; 2009 Aug; 37(8):600-6. PubMed ID: 19526577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
    Nascimento MC; Bisi H; Alves VA; Longatto-Filho A; Kanamura CT; Medeiros-Neto G
    Endocr Pathol; 2001; 12(3):275-9. PubMed ID: 11740048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC.
    Prasad ML; Huang Y; Pellegata NS; de la Chapelle A; Kloos RT
    Histopathology; 2004 Jul; 45(1):39-46. PubMed ID: 15228442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncocytic lesions of the neuroendocrine system.
    Baloch ZW; LiVolsi VA
    Semin Diagn Pathol; 1999 May; 16(2):190-9. PubMed ID: 10452583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experience in Hurthle cell tumors].
    Francomano F; Napolitano L; Scipione P; Savini F; Bajocchi G; Angelucci D
    G Chir; 1998; 19(11-12):449-52. PubMed ID: 9882947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria.
    Renshaw AA
    Cancer; 2002 Oct; 96(5):261-6. PubMed ID: 12378592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hürthle-cell thyroid neoplasms: a clinical enigma].
    Cannizzaro M; Fiorenza G; Garofalo L; De Maria A; Cavallaro N; Pulvirenti A; Veroux PF
    Ann Ital Chir; 1999; 70(4):503-8; discussion 508-9. PubMed ID: 10573612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.